A 29-year-old male patient had severe atopic dermatitis (AD) and alopecia universalis (AU) that could not be controlled by using classic therapy. He started taking upadacitinib and achieved an excellent response for both his AD and AU. Thus, upadacitinib represents a promising therapeutic approach for patients with severe AD and alopecia areata.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11141429 | PMC |
| http://dx.doi.org/10.1016/j.jacig.2024.100269 | DOI Listing |
Publication Analysis
Top Keywords
severe atopic
8
atopic dermatitis
8
dermatitis alopecia
8
alopecia universalis
8
29-year-old male
8
male patient
8
successful treatment
4
treatment severe
4
universalis upadacitinib
4
upadacitinib 29-year-old
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!